VYGR Voyager Therapeutics, Inc. Stock Quote

VYGR [NASD]

Index	-	P/E	8.17	EPS (ttm)	1.04	Insider Own	14.07%	Shs Outstand	37.24M	Perf Week	2.04%
Market Cap	313.48M	Forward P/E	-	EPS next Y	-2.55	Insider Trans	-0.26%	Shs Float	31.68M	Perf Month	1.01%
Income	40.10M	PEG	-	EPS next Q	-0.63	Inst Own	74.90%	Short Float	4.84%	Perf Quarter	-30.61%
Sales	197.30M	P/S	1.59	EPS this Y	55.90%	Inst Trans	0.01%	Short Ratio	4.18	Perf Half Y	-34.51%
Book/sh	4.46	P/B	1.91	EPS next Y	-431.20%	ROA	12.90%	Target Price	14.09	Perf Year	-42.02%
Cash/sh	5.42	P/C	1.57	EPS next 5Y	-	ROE	38.00%	52W Range	6.26 - 14.80	Perf YTD	18.88%
Dividend	-	P/FCF	-	EPS past 5Y	-12.10%	ROI	-51.90%	52W High	-42.57%	Beta	1.12
Dividend %	-	Quick Ratio	5.10	Sales past 5Y	-	Gross Margin	-	52W Low	35.78%	ATR	0.48
Employees	185	Current Ratio	5.10	Sales Q/Q	477.50%	Oper. Margin	18.90%	RSI (14)	52.91	Volatility	5.27% 6.35%
Optionable	Yes	Debt/Eq	0.00	EPS Q/Q	656.40%	Profit Margin	20.30%	Rel Volume	1.46	Prev Close	8.92
Shortable	Yes	LT Debt/Eq	0.00	Earnings	Oct 29 BMO	Payout	0.00%	Avg Volume	366.60K	Price	8.50
Recom	2.20	SMA20	4.15%	SMA50	-0.77%	SMA200	-21.76%	Volume	536,975	Change	-4.71%

Dec-24-20

Downgrade

Cantor Fitzgerald

Overweight → Neutral

$15 → $10

Dec-23-20

Downgrade

Raymond James

Outperform → Mkt Perform

Nov-11-20

Downgrade

Oppenheimer

Outperform → Perform

Nov-10-20

Downgrade

Wells Fargo

Overweight → Equal Weight

$10

Nov-10-20

Downgrade

Raymond James

Strong Buy → Outperform

$28 → $17

Mar-19-20

Initiated

The Benchmark Company

Buy

$18

Feb-06-20

Initiated

Oppenheimer

Outperform

Nov-15-18

Upgrade

Raymond James

Outperform → Strong Buy

Sep-10-18

Resumed

BTIG Research

Buy

$32

Sep-10-18

Downgrade

Morgan Stanley

Overweight → Equal-Weight

Jun-04-18

Initiated

H.C. Wainwright

Buy

$30

Mar-12-18

Downgrade

Wedbush

Outperform → Neutral

$29

Mar-12-18

Downgrade

Evercore ISI

Outperform → In-line

Feb-02-18

Initiated

Morgan Stanley

Overweight

Nov-28-17

Resumed

Piper Jaffray

Overweight

$28

Oct-31-17

Initiated

Robert W. Baird

Outperform

$31

Oct-27-17

Initiated

Canaccord Genuity

Buy

$35

Oct-23-17

Reiterated

Stifel

Buy

$20 → $31

Oct-12-17

Initiated

Raymond James

Outperform

$35

Aug-17-17

Initiated

Evercore ISI

Outperform

$12

Jan-11-21 04:03PM	Voyager Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire
09:21AM	Is the Options Market Predicting a Spike in Voyager (VYGR) Stock? Zacks
Dec-23-20 08:29AM	The Daily Biotech Pulse: Supernus Issues Positive ADHD Readout, Sorrento Files For Emergency Use Authorization For Rapid COVID-19 Test, Inhibikase To Make Wall Street Debut Benzinga -6.53%
Dec-22-20 04:17PM	Voyager Therapeutics Provides Update on NBIb-1817 (VY-AADC) Gene Therapy Program GlobeNewswire
08:51AM	Voyager (VYGR) in Focus: Stock Moves 5.7% Higher Zacks
Dec-09-20 09:43PM	Is VYGR A Good Stock To Buy Now? Insider Monkey
04:02PM	Top Biotech Stocks for Q1 2021 Investopedia
Nov-16-20 09:48AM	A Look Into Healthcare Sector Value Stocks Benzinga
Nov-09-20 05:15PM	Voyager Therapeutics (VYGR) Surpasses Q3 Earnings and Revenue Estimates Zacks
04:00PM	Voyager Therapeutics Announces Third Quarter 2020 Financial Results and Corporate Updates GlobeNewswire
Oct-28-20 12:32PM	Voyager Therapeutics (VYGR) May Report Negative Earnings: Know the Trend Ahead of Q3 Release Zacks
Oct-21-20 08:27PM	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Voyager Therapeutics, Inc. - VYGR GlobeNewswire
Oct-13-20 09:10AM	Why Voyager Therapeutics Stock Is Sinking Today Motley Fool
03:24AM	Voyager Plunges 11% As Huntingtons Treatment Placed On Clinical Hold SmarterAnalyst
Oct-12-20 04:01PM	Voyager Therapeutics Provides Regulatory Update on VY-HTT01 Program GlobeNewswire
Oct-01-20 04:01PM	Voyager Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire
Sep-15-20 04:01PM	Voyager Therapeutics Appoints Nancy Vitale to its Board of Directors GlobeNewswire
Sep-14-20 04:30PM	Voyager Therapeutics Appoints Michelle Quinn Smith as Chief Human Resources Officer GlobeNewswire
Sep-11-20 03:27PM	Parkinson's Disease Patients Get Long-Term Benefits From Experimental Gene Therapy Motley Fool
12:25PM	Reflecting on Voyager Therapeutics' (NASDAQ:VYGR) Share Price Returns Over The Last Year Simply Wall St.
11:36AM	Neurocrine Biosciences and Voyager Therapeutics Present New Long-Term Three-Year Data Demonstrating that One-Time Treatment with an Investigational Gene Therapy Showed Sustained Improvement in Motor Function in Patients with Parkinsons Disease GlobeNewswire
11:32AM	Neurocrine Biosciences and Voyager Therapeutics Present New Long-Term Three-Year Data Demonstrating that One-Time Treatment with an Investigational Gene Therapy Showed Sustained Improvement in Motor Function in Patients with Parkinson's Disease PR Newswire
Sep-03-20 04:29PM	Voyager Therapeutics Announces Upcoming Presentations at the International Parkinson and Movement Disorder Society Virtual Congress 2020 GlobeNewswire
Aug-21-20 10:35AM	Oppenheimer Says These 2 Stocks Could Surge Over 100% From Current Levels TipRanks
Aug-10-20 08:25AM	Voyager Therapeutics (VYGR) Reports Q2 Loss, Tops Revenue Estimates Zacks
07:00AM	Voyager Therapeutics Announces Second Quarter 2020 Financial Results and Corporate Updates GlobeNewswire
Aug-04-20 08:18AM	The Daily Biotech Pulse: Voyager, AbbVie End Collaboration, Thumbs Down For DBV's Peanut Allergy Patch, Tiziana Expedites COVID-19 Trial Plans Benzinga -8.65%
Aug-03-20 04:30PM	Voyager Therapeutics to Report Second Quarter 2020 Financial Results and Participate in Upcoming Investor Conferences GlobeNewswire
04:01PM	Voyager Therapeutics Provides Update on AbbVie Vectorized Antibody Collaborations GlobeNewswire
Jul-08-20 08:49AM	Homology Medicines (FIXX) Looks Good: Stock Adds 8% in Session Zacks
Jun-27-20 01:19PM	Hedge Funds Are Selling Voyager Therapeutics, Inc. (VYGR) Insider Monkey
Jun-17-20 04:04PM	Neurocrine Adds to Pipeline With $2 Billion Takeda Deal GuruFocus.com
Jun-16-20 04:01PM	Voyager Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire
May-12-20 01:40PM	Gene-Therapy Treatments for Tay-Sachs, Sickle Cell, Other Diseases to Be Featured in Online Gathering Barrons.com
May-11-20 12:56PM	Analysts Are Betting On Voyager Therapeutics, Inc. (NASDAQ:VYGR) With A Big Upgrade This Week Simply Wall St. +11.03%
08:30AM	Should You Buy Voyager Therapeutics (VYGR) Ahead of Earnings? Zacks
May-06-20 07:00AM	Voyager Therapeutics Announces First Quarter 2020 Financial Results and Corporate Updates GlobeNewswire
Apr-29-20 07:30AM	Voyager Therapeutics Announces Upcoming Data Presentations at the American Society of Gene and Cell Therapy Virtual 2020 Annual Meeting GlobeNewswire
Apr-28-20 12:33PM	Earnings Preview: Voyager Therapeutics (VYGR) Q1 Earnings Expected to Decline Zacks
Apr-21-20 05:35AM	'You've got to do what you've got to do': Biotech workers assist with COVID-19 response American City Business Journals
Apr-03-20 08:30AM	Voyager Therapeutics Provides Update on the RESTORE-1 Parkinsons Disease Trial GlobeNewswire -6.55%
Mar-26-20 01:51AM	Edited Transcript of VYGR earnings conference call or presentation 3-Mar-20 9:30pm GMT Thomson Reuters StreetEvents
Mar-09-20 08:00AM	Voyager Therapeutics Announces Cancellation of Presentation and Webcast at the Barclays Global Healthcare Conference GlobeNewswire -6.93%
Mar-03-20 05:15PM	Voyager Therapeutics (VYGR) Reports Q4 Loss, Tops Revenue Estimates Zacks
04:01PM	Voyager Therapeutics Announces Fourth Quarter and Full Year 2019 Financial Results and Corporate Updates GlobeNewswire
Feb-26-20 05:00PM	Voyager Therapeutics to Participate in Upcoming Investor Conferences GlobeNewswire -7.62%
Feb-25-20 04:30PM	Voyager Therapeutics to Report Fourth Quarter and Full Year 2019 Financial Results and Corporate Updates on March 3, 2020 GlobeNewswire
Feb-24-20 08:43AM	Why Earnings Season Could Be Great for Voyager Therapeutics (VYGR) Zacks -6.68%
Jan-10-20 10:25AM	Can You Imagine How Voyager Therapeutics's (NASDAQ:VYGR) Shareholders Feel About The 52% Share Price Increase? Simply Wall St.
Dec-17-19 06:00AM	Atlas, MPM, Partners funnel $49M into a new gene-silencing startup American City Business Journals
Dec-11-19 10:32AM	Is Voyager Therapeutics, Inc. (VYGR) Going To Burn These Hedge Funds ? Insider Monkey
Nov-12-19 09:05PM	Edited Transcript of VYGR earnings conference call or presentation 6-Nov-19 1:00pm GMT Thomson Reuters StreetEvents
Nov-06-19 07:35AM	Voyager Therapeutics (VYGR) Reports Q3 Loss, Tops Revenue Estimates Zacks -7.34%
06:22AM	Voyager Therapeutics Announces Third Quarter 2019 Financial Results and Corporate Highlights GlobeNewswire
Oct-31-19 08:00AM	Voyager Therapeutics to Present at the Credit Suisse Healthcare Conference GlobeNewswire
Oct-30-19 04:35PM	Voyager Therapeutics to Host Third Quarter 2019 Financial Results and Corporate Highlights Conference Call GlobeNewswire
10:33AM	Earnings Preview: Voyager Therapeutics (VYGR) Q3 Earnings Expected to Decline Zacks
Oct-28-19 04:14PM	Is Voyager Therapeutics, Inc. (VYGR) Going To Burn These Hedge Funds ? Insider Monkey
Sep-25-19 08:00AM	Voyager Therapeutics to Present at Upcoming Investor Conferences in October 2019 GlobeNewswire
Sep-24-19 09:00AM	CSE New Listing - Voyager Digital (Canada) Ltd Commences Trading on the Canadian Securities Exchange - Video News Alert on Investmentpitch.com Newsfile -6.70%
Sep-02-19 01:07AM	Edited Transcript of VYGR earnings conference call or presentation 9-Aug-19 12:00pm GMT Thomson Reuters StreetEvents
Aug-28-19 08:00AM	Voyager Therapeutics to Present at Upcoming Investor Conferences in September 2019 GlobeNewswire
Aug-09-19 09:23PM	Voyager Therapeutics, Inc. (VYGR) Q2 2019 Earnings Call Transcript Motley Fool
08:25AM	Voyager Therapeutics (VYGR) Q2 Earnings and Revenues Top Estimates Zacks
07:00AM	Voyager Therapeutics Reports Second Quarter 2019 Financial Results and Corporate Highlights GlobeNewswire
Aug-05-19 04:30PM	Voyager Therapeutics to Host Second Quarter 2019 Financial Results and Corporate Highlights Conference Call GlobeNewswire
Aug-02-19 06:04AM	5 years later, Ice Bucket Challenge's impact on drug research still unfolding American City Business Journals
Jul-30-19 04:30PM	Voyager Therapeutics to Present at Upcoming Investor Conferences in August 2019 GlobeNewswire
10:38AM	Earnings Preview: Voyager Therapeutics (VYGR) Q2 Earnings Expected to Decline Zacks
Jul-08-19 10:53AM	Are Voyager Therapeutics, Inc. (NASDAQ:VYGR) Investors Paying Above The Intrinsic Value? Simply Wall St.
Jun-18-19 10:47AM	Did Hedge Funds Drop The Ball On Voyager Therapeutics, Inc. (VYGR) ? Insider Monkey
07:31AM	The Daily Biotech Pulse: PhaseBio Pumped Up, Eiger Exults On Breakthrough Therapy Designation, Biohaven Slips On Stock Sale Benzinga
Jun-17-19 07:30AM	Voyager Therapeutics Announces Restructured Gene Therapy Relationship with Sanofi Genzyme and Portfolio Update GlobeNewswire +10.35%
Jun-11-19 04:30PM	Voyager Therapeutics to Present at the Raymond James Life Sciences & MedTech Conference GlobeNewswire
May-30-19 02:36PM	3 Top Gene Therapy Stocks That Could Soar InvestorPlace
May-20-19 04:30PM	Voyager Therapeutics Announces Management Updates GlobeNewswire
May-07-19 08:35AM	Voyager Therapeutics (VYGR) Reports Q1 Loss, Tops Revenue Estimates Zacks
07:27AM	Voyager Therapeutics: 1Q Earnings Snapshot Associated Press
07:05AM	Voyager Therapeutics Reports First Quarter 2019 Financial Results and Corporate Highlights GlobeNewswire
May-05-19 09:05AM	Neurocrine Biosciences and Voyager Therapeutics Announce Phase I Results for VY-AADC in Patients with Parkinsons Disease at the American Academy of Neurology Annual Meeting GlobeNewswire
May-02-19 10:32AM	Analysts Estimate Voyager Therapeutics (VYGR) to Report a Decline in Earnings: What to Look Out for Zacks
Apr-30-19 10:37AM	What Are Analysts Expecting From Voyager Therapeutics, Inc. (NASDAQ:VYGR) Over The Next Few Years? Simply Wall St.
Apr-29-19 07:04AM	Voyager Therapeutics Announces New Data in Multiple Presentations at the American Society of Gene and Cell Therapy 2019 Annual Meeting GlobeNewswire
Apr-15-19 12:25PM	Voyager Therapeutics Announces Upcoming Data Presentations at the American Society of Gene and Cell Therapy 2019 Annual Meeting GlobeNewswire
Apr-03-19 04:15PM	Voyager Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635 (c)(4) GlobeNewswire
Apr-02-19 04:15PM	Voyager Therapeutics to Present at the H.C. Wainwright Global Life Sciences Conference GlobeNewswire +7.38%
Mar-28-19 04:15PM	Neurocrine Biosciences and Voyager Therapeutics Announce Publication of Phase 1b Trial Results of VY-AADC for Parkinsons Disease in the Annals of Neurology GlobeNewswire
Mar-11-19 08:00AM	MRI Interventions Announces Collaboration with Voyager Therapeutics for the Design, Manufacture and Supply of V-TAG Device GlobeNewswire +7.28%
Mar-10-19 10:36AM	10 Stocks For The Gene Therapy Revolution Investopedia
Mar-08-19 08:00AM	Rare Disease Therapies Draw Big Biopharma's Interest ACCESSWIRE
Mar-06-19 07:50AM	Consolidated Research: 2019 Summary Expectations for AMC Entertainment, Spirit Airlines, Voyager Therapeutics, CIT Group, Kaman, and CommVault Fundamental Analysis, Key Performance Indications GlobeNewswire -5.29%
Mar-04-19 05:03PM	Here's Why Voyager Therapeutics Stock Rose as Much as 13% Today Motley Fool +10.24%
Mar-01-19 09:29PM	Why Big Pharma Is Diving Into Gene Therapy Barrons.com +10.00%
Feb-28-19 10:32PM	Edited Transcript of VYGR earnings conference call or presentation 26-Feb-19 9:30pm GMT Thomson Reuters StreetEvents
Feb-26-19 09:22PM	Voyager Therapeutics, Inc. (VYGR) Q4 2018 Earnings Conference Call Transcript Motley Fool
04:05PM	Voyager Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results and Corporate Highlights GlobeNewswire
Feb-25-19 08:19AM	AbbVie Extends Deal With Voyager to Make Parkinson's Drugs Zacks +5.64%
Feb-22-19 02:40PM	Watch These Four Biotech Stocks Friday ACCESSWIRE +22.85%
12:25PM	Why Voyager Therapeutics Is Skyrocketing Today Motley Fool
11:31AM	Voyager Therapeutics stock jumps on 2nd Parkinson's deal American City Business Journals

Voyager Therapeutics, Inc., a clinical-stage gene therapy company, focuses on the development of treatments for patients suffering from severe neurological diseases. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1b clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyotrophic lateral sclerosis; VY-HTT01 for Huntington's disease; VY-FXN01 for Friedreich's ataxia; Tau program for the treatment of tauopathies, including Alzheimer's disease, progressive supranuclear palsy, and frontotemporal dementia; and alpha-synuclein program for synucleinopathies, Parkinson's disease, Lewy Body Dementia, and multiple system atrophy. The company has strategic collaboration agreements with the University of Massachusetts; and ClearPoint Neuro, Inc., as well as collaborations with Brammer Bio and Fujifilm Diosynth Biotechnologies to support the development of its gene therapy programs. It also has a collaboration and license agreement with Neurocrine Biosciences, Inc. for the research, development, and commercialization of adeno-associated virus-based gene therapy products. Voyager Therapeutics, Inc. was founded in 2013 and is headquartered in Cambridge, Massachusetts.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Turenne Andre	President & CEO	Jan 12	Sale	8.62	10,443	90,019	156,352	Jan 14 05:59 PM
Dorval Allison	Chief Financial Officer	Jan 12	Sale	8.62	2,942	25,360	49,080	Jan 14 05:57 PM
Khwaja Omar	See remarks	May 21	Sale	12.96	3,500	45,360	56,500	May 22 06:15 PM
Hesslein Robert W.	Senior VP & General Counsel	Apr 03	Sale	8.51	3,091	26,304	52,534	Apr 07 05:24 PM
Turenne Andre	President & CEO	Jan 21	Sale	13.36	10,705	143,019	85,545	Jan 29 05:26 PM
Ottmer Matthew P.	Chief Operating Officer	Jan 21	Sale	13.36	3,724	49,753	26,276	Jan 29 05:26 PM
Dorval Allison	Chief Financial Officer	Jan 21	Sale	13.36	3,128	41,790	24,522	Jan 29 05:27 PM

open in yahoo | open in reuters | open in google

Upgrade your FINVIZ experience